Homepage

Everything that a bio-entrepreneur needs, all in one location.

Learn more about Bakar Labs (2:06)

There has never been a shortage of entrepreneurs with great ideas designed to tackle the most pressing global challenges — from human health to environmental sustainability.

To grow those ideas into successful ventures, entrepreneurs need space, equipment, and multiple connections to a vibrant ecosystem. That’s why we created Bakar Bio Labs at UC Berkeley. Bakar Bio Labs is built to be the foundational hub for resources where startups thrive.

Agilent customer story: Rocío Sampayo, Axent Biosciences

AGILENT – Learn how Axent Biosciences is advancing manufacturing solutions to expand access to cell therapies. Read post

HexemBio looks beyond capital as KIP opens a door to Korea’s biotech network

KOREA TECH DESK – HexemBio, a U.S. preclinical biotech developing therapies designed to rejuvenate aging blood stem cells, announced a USD 10.4 million seed round led by Draper Associates in April 2026. By September, the company said its total funding had reached USD 15.5 million, with Korea Investment Partners investing USD 2 million through the KIPUS Trinitas Fund. Read post
Ali Madani

Profluent and BioMarin Partner to Design Novel Enzyme Therapies Using AI

HLTH – The two companies have entered a collaboration focused on designing and optimizing novel enzyme therapies for BioMarin’s pipeline, combining artificial intelligence-based protein design with the pharmaceutical company’s experience developing enzyme replacement therapies for genetically defined conditions. Read post
Bakar Labs in numbers
Powered by QB3

Built for startups. For more than 20 years, QB3 has been the University of California’s center for innovation and entrepreneurship in life science. Through pitch summits, seminars, symposia, podcasts, office hours, internships, and workshops QB3 educates, connects, and elevates the entrepreneurial ecosystem.

Learn about QB3
Decorative graphic of QB3 structure